Manickam Muruganandham
Department of Radiation Physics, Division of Radiation Oncology
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Radiation Physics - Patient Care, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1999 | University of Delhi, Delhi, IND, PHD, Physics (Biomedical MR) |
| 1994 | National Institute of Mental Health and Neuro-Sciences (NIMHANS), Bangalore, IND, MPH, Biophysics |
| 1989 | Anna University, College of Engineering / Adyar Cancer Institute, Madras, IND, MS, Medical Physics |
| 1987 | University of Madras, Madras, IND, BS, Physics |
Postgraduate Training
| 2000-2003 | Research Fellowship, Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY |
Board Certifications
| 2011 | • American Board of Radiology (ABR) – Therapeutic Radiological Physics |
Experience & Service
Academic Appointments
Assistant Professor, Division of Radiation Oncology, University of Iowa Hospitals and Clinics, Iowa City, IA, 2006 - 2013
Instructor, Division of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, 2003 - 2006
Administrative Appointments/Responsibilities
Member, The University of iowa - Holden Comprehensive Care Center, Iowa City, IA, 2007 - 2013
Honors & Awards
| 2002 | International Society for Magnetic Resonance in Medicine (ISMRM) travel award to Honolulu, Hawaii, International Society for Magnetic Resonance in Medicine |
| 1998 | International Society for Magnetic Resonance in Medicine (ISMRM) travel award to Sydney, Australia, International Society for Magnetic Resonance in Medicine |
Selected Publications
Peer-Reviewed Articles
- Schindel J, Muruganandham M, Pigge FC, Anderson J, Kim Y. Magnetic Resonance Imaging (MRI) Markers for MRI-Guided High-Dose-Rate Brachytherapy: Novel Marker-Flange for Cervical Cancer and Marker Catheters for Prostate Cancer. Int J Radiat Oncol Biol Phys. e-Pub 2013. PMID: 23433797.
- Kim Y, Muruganandham M, Modrick JM, Bayouth JE. Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer. Int J Radiat Oncol Biol Phys 80(3):947-55, 2011. e-Pub 2010. PMID: 20934275.
- Kalderon N, Muruganandham M, Koutcher JA, Potuzak M. Therapeutic strategy for acute spinal cord contusion injury: cell elimination combined with microsurgical intervention. PLoS One 2(6):e565, 2007. e-Pub 2007. PMID: 17637827.
- Muruganandham M, Lupu M, Dyke JP, Matei C, Linn M, Packman K, Kolinsky K, Higgins B, Koutcher JA. Preclinical evaluation of tumor microvascular response to a novel antiangiogenic/antitumor agent RO0281501 by dynamic contrast-enhanced MRI at 1.5 T. Mol Cancer Ther 5(8):1950-7, 2006. PMID: 16928815.
- Muruganandham M, Alfieri AA, Matei C, Chen Y, Sukenick G, Schemainda I, Hasmann M, Saltz LB, Koutcher JA. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy. Clin Cancer Res 11(9):3503-13, 2005. PMID: 15867253.
- Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, Muruganandham M, Ebora L, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234(3):804-14, 2005. PMID: 15734935.
- Muruganandham M, Koutcher JA, Pizzorno G, He Q. In vivo tumor lactate relaxation measurements by selective multiple-quantum-coherence (Sel-MQC) transfer. Magn Reson Med 52(4):902-6, 2004. PMID: 15389963.
- Shukla-Dave A, Hricak H, Eberhardt SC, Olgac S, Muruganandham M, Scardino PT, Reuter VE, Koutcher JA, Zakian KL. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. Radiology 231(3):717-24, 2004. PMID: 15163811.
- Zakian KL, Eberhardt S, Hricak H, Shukla-Dave A, Kleinman S, Muruganandham M, Sircar K, Kattan MW, Reuter VE, Scardino PT, Koutcher JA. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results. Radiology 229(1):241-7, 2003. e-Pub 2003. PMID: 12920178.
- Muruganandham M, Kasiviswanathan A, Jagannathan NR, Raghunathan P, Jain PC, Jain V. Diltiazem enhances tumor blood flow: MRI study in a murine tumor. Int J Radiat Oncol Biol Phys 43(2):413-21, 1999. PMID: 10030270.
- Sreenivasan R, Muruganandham M, Sharma M, Joshi PG, Joshi NB. Binding of monomeric and oligomeric porphyrins to human glioblastoma (U-87MG) cells and their photosensitivity. Cancer Lett 120(1):45-51, 1997. PMID: 9570385.
Grant & Contract Support
| Title: | • Role of imaging in pre-treatment risk assessment of prostate cancer patients |
| Funding Source: | NIH/NCI |
| Role: | Co-Investigator |
Patient Reviews
CV information above last modified August 20, 2024